Competitive intelligence on
small-molecule drugs and
the 90,000 global patents
|Title:||Terazosin polymorph and pharmaceutical composition|
|Abstract:||A novel anhydrous crystalline polymorph of 1-(4-amino-6,7-dimethoxy- 2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine monohydrochloride is disclosed, together with pharmaceutical formulations containing the compound. The novel polymorph exhibits a diminished food effect when administered to human subjects.|
|Inventor(s):||Meyer; Glenn A. (Waukegan, IL), Bauer; John F. (Lake Bluff, IL)|
|Assignee:||Abbott Laboratories (Abbott Park, IL)|
Patent Claim Types:|
see list of patent claims
|Compound; Composition; Dosage form; Use;|
|Country||Document Number||Publication Date|
|European Patent Office||0622067||Nov 02, 1994|
|Germany||623612||Aug 24, 1995|
|European Patent Office||0683167||Nov 22, 1995|
|Canada||2107382||Oct 30, 1994|
|Spain||2089665||Oct 01, 1996|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.